EU Regulators Recommend Golimumab for Ulcerative ColitisEU Regulators Recommend Golimumab for Ulcerative Colitis

The FDA approved the anti-inflammatory drug for this indication just 2 months earlier. International Approvals

Source: Medscape Today Headlines - July 26, 2013 Category: Consumer Health News Tags: Gastroenterology News Alert Source Type: news